Formate as an auxiliary substrate for glucose-limited cultivation of Penicillium chrysogenum: impact on penicillin G production and biomass yield. 2007

Diana M Harris, and Zita A van der Krogt, and Walter M van Gulik, and Johannes P van Dijken, and Jack T Pronk
Delft University of Technology, Department of Biotechnology, Julianalaan 67, Delft, The Netherlands.

Production of beta-lactams by the filamentous fungus Penicillium chrysogenum requires a substantial input of ATP. During glucose-limited growth, this ATP is derived from glucose dissimilation, which reduces the product yield on glucose. The present study has investigated whether penicillin G yields on glucose can be enhanced by cofeeding of an auxiliary substrate that acts as an energy source but not as a carbon substrate. As a model system, a high-producing industrial strain of P. chrysogenum was grown in chemostat cultures on mixed substrates containing different molar ratios of formate and glucose. Up to a formate-to-glucose ratio of 4.5 mol.mol(-1), an increasing rate of formate oxidation via a cytosolic NAD(+)-dependent formate dehydrogenase increasingly replaced the dissimilatory flow of glucose. This resulted in increased biomass yields on glucose. Since at these formate-to-glucose ratios the specific penicillin G production rate remained constant, the volumetric productivity increased. Metabolic modeling studies indicated that formate transport in P. chrysogenum does not require an input of free energy. At formate-to-glucose ratios above 4.5 mol.mol(-1), the residual formate concentrations in the cultures increased, probably due to kinetic constraints in the formate-oxidizing system. The accumulation of formate coincided with a loss of the coupling between formate oxidation and the production of biomass and penicillin G. These results demonstrate that, in principle, mixed-substrate feeding can be used to increase the yield on a carbon source of assimilatory products such as beta-lactams.

UI MeSH Term Description Entries
D010400 Penicillin G A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission. Benzylpenicillin,Benpen,Benzylpenicillin Potassium,Coliriocilina,Crystapen,Or-pen,Parcillin,Pekamin,Pengesod,Penibiot,Penicilina G Llorente,Penicillin G Jenapharm,Penicillin G Potassium,Penicillin G Sodium,Penicillin Grünenthal,Penilevel,Peniroger,Pfizerpen,Sodiopen,Sodipen,Sodium Benzylpenicillin,Sodium Penicillin,Unicilina,Ursopen,Van-Pen-G
D010408 Penicillium chrysogenum A mitosporic fungal species used in the production of penicillin. Penicillium chrysogeum,Penicillium notatum
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D005561 Formates Derivatives of formic acids. Included under this heading are a broad variety of acid forms, salts, esters, and amides that are formed with a single carbon carboxy group. Formic Acids,Acids, Formic
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000332 Aerobiosis Life or metabolic reactions occurring in an environment containing oxygen. Aerobioses
D001709 Biotechnology Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level (i.e., GENETIC ENGINEERING) is a central focus; laboratory methods used include TRANSFECTION and CLONING technologies, sequence and structure analysis algorithms, computer databases, and gene and protein structure function analysis and prediction. Biotechnologies
D047090 beta-Lactams Four-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, as well as the CEPHALOSPORINS based on a bicyclo-thiazine, and including monocyclic MONOBACTAMS. The BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria. beta-Lactam,4-Thia-1-Azabicyclo(3.2.0)Heptanes,4-Thia-1-Azabicyclo(4.2.0)Octanes,beta Lactam,beta Lactams
D018533 Biomass Total mass of all the organisms of a given type and/or in a given area. (From Concise Dictionary of Biology, 1990) It includes the yield of vegetative mass produced from any given crop. Biomasses

Related Publications

Diana M Harris, and Zita A van der Krogt, and Walter M van Gulik, and Johannes P van Dijken, and Jack T Pronk
October 2019, Biotechnology journal,
Diana M Harris, and Zita A van der Krogt, and Walter M van Gulik, and Johannes P van Dijken, and Jack T Pronk
September 1995, Journal of biotechnology,
Diana M Harris, and Zita A van der Krogt, and Walter M van Gulik, and Johannes P van Dijken, and Jack T Pronk
June 2012, Omics : a journal of integrative biology,
Diana M Harris, and Zita A van der Krogt, and Walter M van Gulik, and Johannes P van Dijken, and Jack T Pronk
November 1990, Journal of industrial microbiology,
Diana M Harris, and Zita A van der Krogt, and Walter M van Gulik, and Johannes P van Dijken, and Jack T Pronk
February 1979, Biotechnology and bioengineering,
Diana M Harris, and Zita A van der Krogt, and Walter M van Gulik, and Johannes P van Dijken, and Jack T Pronk
September 1990, Biotechnology and bioengineering,
Diana M Harris, and Zita A van der Krogt, and Walter M van Gulik, and Johannes P van Dijken, and Jack T Pronk
May 1973, Journal of general microbiology,
Diana M Harris, and Zita A van der Krogt, and Walter M van Gulik, and Johannes P van Dijken, and Jack T Pronk
August 2011, Biotechnology journal,
Diana M Harris, and Zita A van der Krogt, and Walter M van Gulik, and Johannes P van Dijken, and Jack T Pronk
January 1997, Biotechnology and bioengineering,
Diana M Harris, and Zita A van der Krogt, and Walter M van Gulik, and Johannes P van Dijken, and Jack T Pronk
January 1954, Acta physiologica Polonica,
Copied contents to your clipboard!